Chile · Delayed Price · Currency is CLP SNSE:SOPROCAL Statistics
Total Valuation
SNSE:SOPROCAL has a market cap or net worth of CLP 2.66 billion. The enterprise value is 2.87 billion.
| Market Cap | 2.66B |
| Enterprise Value | 2.87B |
Important Dates
The next estimated earnings date is Monday, September 15, 2025.
| Earnings Date | Sep 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SNSE:SOPROCAL has 9.85 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 9.85M |
| Shares Outstanding | 9.85M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | +1.25% |
| Owned by Insiders (%) | 10.06% |
| Owned by Institutions (%) | n/a |
| Float | 2.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.21 |
| PB Ratio | 0.46 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | 18.35 |
| P/OCF Ratio | 3.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.58, with an EV/FCF ratio of 19.77.
| EV / Earnings | -14.16 |
| EV / Sales | 0.23 |
| EV / EBITDA | 8.58 |
| EV / EBIT | n/a |
| EV / FCF | 19.77 |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.64 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.79 |
| Debt / FCF | 2.02 |
| Interest Coverage | -5.23 |
Financial Efficiency
Return on equity (ROE) is -3.43% and return on invested capital (ROIC) is -1.60%.
| Return on Equity (ROE) | -3.43% |
| Return on Assets (ROA) | -0.93% |
| Return on Invested Capital (ROIC) | -1.60% |
| Return on Capital Employed (ROCE) | -2.43% |
| Revenue Per Employee | 181.69M |
| Profits Per Employee | -2.89M |
| Employee Count | 71 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 3.03 |
Taxes
| Income Tax | -400.23M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 270.50 |
| 200-Day Moving Average | 270.50 |
| Relative Strength Index (RSI) | 48.15 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SNSE:SOPROCAL had revenue of CLP 12.72 billion and -202.65 million in losses. Loss per share was -20.56.
| Revenue | 12.72B |
| Gross Profit | 2.20B |
| Operating Income | -159.58M |
| Pretax Income | -602.95M |
| Net Income | -202.65M |
| EBITDA | 369.68M |
| EBIT | -159.58M |
| Loss Per Share | -20.56 |
Balance Sheet
The company has 71.59 million in cash and 293.22 million in debt, giving a net cash position of -221.64 million or -22.50 per share.
| Cash & Cash Equivalents | 71.59M |
| Total Debt | 293.22M |
| Net Cash | -221.64M |
| Net Cash Per Share | -22.50 |
| Equity (Book Value) | 5.81B |
| Book Value Per Share | 591.51 |
| Working Capital | 2.52B |
Cash Flow
In the last 12 months, operating cash flow was 797.08 million and capital expenditures -651.90 million, giving a free cash flow of 145.18 million.
| Operating Cash Flow | 797.08M |
| Capital Expenditures | -651.90M |
| Free Cash Flow | 145.18M |
| FCF Per Share | 14.74 |
Margins
Gross margin is 17.29%, with operating and profit margins of -1.25% and -1.59%.
| Gross Margin | 17.29% |
| Operating Margin | -1.25% |
| Pretax Margin | -4.74% |
| Profit Margin | -1.59% |
| EBITDA Margin | 2.91% |
| EBIT Margin | -1.25% |
| FCF Margin | 1.14% |
Dividends & Yields
SNSE:SOPROCAL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.07% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.61% |
| FCF Yield | 5.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNSE:SOPROCAL has an Altman Z-Score of 2.1 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.1 |
| Piotroski F-Score | 4 |